China Pharma Holdings (CPHI) Cash from Investing Activities Growth (3y) (2013 - 2025)
China Pharma Holdings (CPHI) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.16% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 26.15% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 75.05% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -129.09% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.94% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -212.48% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 37.22% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -55.44% |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30.29% |
| Sep 30, 2025 | 45.63% |
| Jun 30, 2025 | 42.94% |
| Mar 31, 2025 | -247.41% |
| Dec 31, 2024 | -238.16% |
| Sep 30, 2024 | 26.46% |
| Dec 31, 2023 | -26.40% |
| Sep 30, 2023 | 36.17% |
| Jun 30, 2023 | 26.18% |
| Mar 31, 2023 | 29.28% |
| Dec 31, 2022 | 36.49% |
| Sep 30, 2022 | -174.57% |
| Jun 30, 2022 | -712.52% |
| Mar 31, 2022 | 73.40% |
| Dec 31, 2021 | 26.56% |
| Sep 30, 2021 | -398.89% |
| Dec 31, 2020 | 75.04% |
| Sep 30, 2020 | -155.71% |
| Jun 30, 2020 | -169.46% |
| Mar 31, 2020 | -135.50% |